Table 6.
Prediction results for withdrawn and marketed drugs.
| Drug Name | State | The number of predicted antitargets |
|---|---|---|
| Amineptine | withdrawn | 13 |
| Duract | withdrawn | 8 |
| Vioxx | withdrawn | 7 |
| Astemizole | withdrawn | 17 |
| Cerivastatin | withdrawn | 8 |
| Chlormezanone | withdrawn | 10 |
| Fenfluramine | withdrawn | 11 |
| Flosequinan | withdrawn | 11 |
| Glafenine | withdrawn | 14 |
| Grepafloxacin | withdrawn | 12 |
| Mibefradil | withdrawn | 16 |
| Rofecoxib | withdrawn | 7 |
| Troglitazone | withdrawn | 14 |
| Ximelagatran | withdrawn | 14 |
| Aspirin | marketed | 2 |
| Ibuprofen | marketed | 2 |
| Valtrex | marketed | 3 |
| Microzide | marketed | 3 |
| Neurontin | marketed | 3 |
| Enoxaparin | marketed | 2 |
| Lyrica | marketed | 2 |